Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress
· natera, investor relations: mike brophy, [email protected], cfo, [email protected]: lesley bogdanow, vp of corporate communications, inc.
Source Summary
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced its robust scientific presence at the upcoming American Transplant Congress (ATC), taking place June 20-24, 2026. The company and its collaborators will share 21 presentations, including seven oral presentations, highlighting the utility of the Prospera test to inform risk assessment and long-term graft monitoring across kidney, heart, lung, and multi-organ transp
Advertisement